Contraceptive Devices Market Trends

  • Report ID: 3835
  • Published Date: Sep 24, 2025
  • Report Format: PDF, PPT

Contraceptive Devices Market - Growth Drivers and Challenges

Growth Drivers

  • Favorable demographics and population trends: The growing population of Earth, especially in developing regions, creates a notable demand for effective birth control, hence fueling the market. According to the United Nations report, the number of people living worldwide is predicted to surpass 10.0 billion by the end of the 20th century, with over 227,000 babies being born daily. As a result, the number of younger demographics entering reproductive age is amplifying, which requires access to a wide range of contraceptive options.
  • Emerging trend of modern birth control approach: The contraceptive devices market is evolving with revolutionary technological progress, translating to safer, more effective, and user-friendly products. Ongoing advances, such as hormone-releasing IUDs, biodegradable implants, and self-administered tools, already improved user experience and efficacy, prompting more individuals to invest in this category. Further, to capitalize on this trend, in February 2024, Bayer and Daré Bioscience allied to expand current contraceptive methods by developing a hormone-free monthly contraceptive ring for vaginal insertion that can stay effective over three weeks without any action required.
  • Initiatives to promote reproductive decisions: Public authorities around the world are updating their strategies to control population growth and improve maternal health through bulk procurement and distribution of products available in the market. Particularly, government-backed subsidies, free distribution programs, and incentives for sterilization or IUD adoption are becoming highly common in high-population countries, such as China and India. For instance, India started realizing its 2030 commitment to securing access to a range of contraceptives with the addition of new choices with an aim to improve healthy timing and spacing of pregnancies (HTSP) through postpartum family planning (PPFP).

Historical Overview of the Global Demographics in the Market

STI-related Global Statistics and Health Impacts (2020)

Type of STI

Demographic Trend

Chlamydia

129 million new infections

Gonorrhoea

82 million new infections

Syphilis

7.1 million new infections

Trichomoniasis

156 million new infections

Genital Herpes (HSV)

520 million people living with it

HPV Infection

300 million women infected (primary cause of cervical cancer)

Source: WHO

Challenges

  • Concerns about user compliance and social stigma: The cases of side effects, such as hormonal imbalances, weight gain, and discomfort, from using these devices often lead to discontinuation. Besides, in many underserved regions, a lack of awareness about available options and persistent social restrictions on usage also contribute to underutilization in the contraceptive devices market. Moreover, the limited autonomy of women over reproductive health decisions due to patriarchal norms and societal pressure imposes an unavoidable limitation on widespread adoption in this sector.

Base Year

2024

Forecast Year

2026-2035

CAGR

5%

Base Year Market Size (2025)

USD 11.4 billion

Forecast Year Market Size (2035)

USD 17.6 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the contraceptive devices market was over USD 11.4 billion.

The market size for the contraceptive devices market is projected to reach USD 17.6 billion by the end of 2035, expanding at a CAGR of 5% during the forecast period, i.e., between 2026-2035.

The major players in the market are Bayer AG, Merck & Co., Inc. (MSD), Pfizer Inc., AbbVie Inc., Reckitt Benckiser Group plc, CooperCompanies, and others.

In terms of technology, the hormonal contraceptives segment is anticipated to garner the largest market share of 65.3% by 2035 and display lucrative growth opportunities during 2026-2035.

The market in North America is projected to hold the largest market share of 50.1% by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos